Monte Rosa Therapeutics, Inc. (GLUE)
9.31
-1.00
(-9.70%)
USD |
NASDAQ |
Nov 12, 16:00
9.50
+0.19
(+2.04%)
After-Hours: 20:00
Monte Rosa Therapeutics Market Cap : 795.36M for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 795.36M |
| November 11, 2026 | 880.80M |
| November 10, 2026 | 897.03M |
| November 09, 2026 | 903.86M |
| November 06, 2026 | 903.01M |
| November 05, 2026 | 875.67M |
| November 04, 2026 | 924.37M |
| November 03, 2026 | 889.34M |
| November 02, 2026 | 905.96M |
| October 30, 2026 | 917.04M |
| October 29, 2026 | 926.41M |
| October 28, 2026 | 924.71M |
| October 27, 2026 | 908.51M |
| October 26, 2026 | 893.17M |
| October 23, 2026 | 923.85M |
| October 22, 2026 | 946.87M |
| October 21, 2026 | 956.24M |
| October 20, 2026 | 968.17M |
| October 19, 2026 | 908.51M |
| October 16, 2026 | 830.11M |
| October 15, 2026 | 862.49M |
| October 14, 2026 | 838.63M |
| October 13, 2026 | 842.89M |
| October 12, 2026 | 896.58M |
| October 09, 2026 | 877.83M |
| Date | Value |
|---|---|
| October 08, 2026 | 879.54M |
| October 07, 2026 | 866.75M |
| October 06, 2026 | 841.18M |
| October 05, 2026 | 875.28M |
| October 02, 2026 | 894.88M |
| October 01, 2026 | 959.65M |
| September 30, 2026 | 1.017B |
| September 29, 2026 | 1.001B |
| September 28, 2026 | 998.00M |
| September 25, 2026 | 1.003B |
| September 24, 2026 | 998.85M |
| September 23, 2026 | 1.013B |
| September 22, 2026 | 1.074B |
| September 21, 2026 | 1.045B |
| September 18, 2026 | 1.034B |
| September 17, 2026 | 1.074B |
| September 16, 2026 | 1.078B |
| September 15, 2026 | 1.107B |
| September 14, 2026 | 1.185B |
| September 11, 2026 | 1.199B |
| September 10, 2026 | 1.220B |
| September 09, 2026 | 1.215B |
| September 08, 2026 | 1.216B |
| September 04, 2026 | 1.180B |
| September 03, 2026 | 1.226B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| United Therapeutics Corp. | 25.15B |
| ACADIA Pharmaceuticals, Inc. | 3.134B |
| Alnylam Pharmaceuticals, Inc. | 20.97B |
| Anika Therapeutics, Inc. | 184.97M |
| Savara, Inc. | 970.13M |
Market Cap Related Metrics
| PS Ratio | 12.43 |
| Price to Book Value | 1.603 |
| Price | 9.31 |
| Earnings Yield | -16.64% |